Lynx1 Capital Management LP, 10% Owner at Cullinan Therapeutics, Inc. (CGEM), bought 556,300 shares at $6.46 ($3.6M) on 2025-10-08, disclosed to the SEC on 2025-10-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| KRRO | BUY | 2026-04-02 | $6K | — | Filing → |
| TCRX | BUY | 2025-12-23 | $218K | — | Filing → |
| NEUP | BUY | 2025-10-23 | $6.6M | — | Filing → |